MedDataX Logo

Long-term Observation PMS for Afatinib

NCT ID: NCT02131259

Last Updated: 2018-09-07

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1605 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-05-07

Study Completion Date

2016-12-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In Japan, post-approval execution of post marketing surveillance (PMS) is requested by the Japanese Pharmaceutical Affairs Law (J-PAL) in order to accumulate safety and efficacy data for reexamination. Reexamination period is defined by J-PAL. Eight years after approval of a new substance, results of PMS need to be submitted as a part of reexamination dossier to the Japanese regulatory authority, the Ministry of Health, Labour and Welfare (MHLW).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

GIOTRIF rPMS in Korean Patients With NSCLC

NCT02285361

Carcinoma, Non-Small-Cell Lung
COMPLETED

GIOTRIF in First Line Therapy of Advanced NSCLC With EGFR-mutations

NCT02047903

Carcinoma, Non-Small-Cell Lung
COMPLETED

Evaluate the Impact of Afatinib on Quality of Life and Symptom Burden of Greek Subjects With Advanced NSCLC in Routine Patient Care Settings

NCT02440854

Carcinoma, Non-Small-Cell Lung
COMPLETED

Non-interventional Study for Real-world Data of Afatinib Treatment in First-line Setting and of Subsequent Therapies for Patients With Advanced Epidermal Growth Factor Receptor (EGFR) Mutation-positive Lung Adenocarcinoma

NCT04795245

Non-squamous, Non-Small Cell Lung Cancer
COMPLETED

Afatinib Combined With Chemotherapy as Conversion Therapy in Unresectable EGFR Sensitive Mutation-positive Stage III NSCLC

NCT06709859

Carcinoma, Non-Small-Cell Lung
RECRUITING PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Carcinoma, Non-Small-Cell Lung

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Afatinib

Afatinib dimaleate

Intervention Type DRUG

20mg - 50mg

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Afatinib dimaleate

20mg - 50mg

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Patients with Epidermal Growth Factor Receptor (EGFR) mutation-positive inoperable or recurrent non-small cell lung cancer (NSCLC)will be included.

Exclusion Criteria

\- None
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boehringer Ingelheim

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Boehringer Ingelheim

Role: STUDY_CHAIR

Boehringer Ingelheim

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Boehringer Ingelheim Investigational Site 145

Adachi Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 429

Aira Kagoshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 64

Aizuwakamatsu Fukushima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 44

Akita Akita, , Japan

Site Status

Boehringer Ingelheim Investigational Site 45

Akita Akita, , Japan

Site Status

Boehringer Ingelheim Investigational Site 46

Akita Akita, , Japan

Site Status

Boehringer Ingelheim Investigational Site 47

Akita Akita, , Japan

Site Status

Boehringer Ingelheim Investigational Site 333

Amagasaki Hyogo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 266

Anjo Aichi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 27

Aomori Aomori, , Japan

Site Status

Boehringer Ingelheim Investigational Site 28

Aomori Aomori, , Japan

Site Status

Boehringer Ingelheim Investigational Site 127

Asahi Chiba, , Japan

Site Status

Boehringer Ingelheim Investigational Site 128

Asahi Chiba, , Japan

Site Status

Boehringer Ingelheim Investigational Site 18

Asahikawa Hokkaido, , Japan

Site Status

Boehringer Ingelheim Investigational Site 19

Asahikawa Hokkaido, , Japan

Site Status

Boehringer Ingelheim Investigational Site 20

Asahikawa Hokkaido, , Japan

Site Status

Boehringer Ingelheim Investigational Site 21

Asahikawa Hokkaido, , Japan

Site Status

Boehringer Ingelheim Investigational Site 198

Atsugi Kanagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 294

Ayabe Kyoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 142

Bunkyo Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 143

Bunkyo Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 144

Bunkyo Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 112

Chiba Chiba, , Japan

Site Status

Boehringer Ingelheim Investigational Site 113

Chiba Chiba, , Japan

Site Status

Boehringer Ingelheim Investigational Site 114

Chiba Chiba, , Japan

Site Status

Boehringer Ingelheim Investigational Site 115

Chiba Chiba, , Japan

Site Status

Boehringer Ingelheim Investigational Site 116

Chiba Chiba, , Japan

Site Status

Boehringer Ingelheim Investigational Site 117

Chiba Chiba, , Japan

Site Status

Boehringer Ingelheim Investigational Site 402

Chikugo Fukuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 16

Chitose Hokkaido, , Japan

Site Status

Boehringer Ingelheim Investigational Site 132

Chiyoda Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 133

Chiyoda Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 134

Chiyoda Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 135

Chuo Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 136

Chuo Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 234

Chuo Yamanashi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 235

Chuo Yamanashi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 48

Daisen Akita, , Japan

Site Status

Boehringer Ingelheim Investigational Site 147

Edogawa Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 148

Edogawa Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 173

Fuchu Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 257

Fuji Shizuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 260

Fujieda Shizuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 97

Fujioka Gumma, , Japan

Site Status

Boehringer Ingelheim Investigational Site 203

Fujisawa Kanagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 111

Fukaya Saitama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 231

Fukui Fukui, , Japan

Site Status

Boehringer Ingelheim Investigational Site 232

Fukui Fukui, , Japan

Site Status

Boehringer Ingelheim Investigational Site 393

Fukuoka Fukuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 394

Fukuoka Fukuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 395

Fukuoka Fukuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 396

Fukuoka Fukuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 399

Fukuoka Fukuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 58

Fukushima Fukushima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 59

Fukushima Fukushima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 60

Fukushima Fukushima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 356

Fukuyama Hiroshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 357

Fukuyama Hiroshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 121

Funabashi Chiba, , Japan

Site Status

Boehringer Ingelheim Investigational Site 251

Gifu Gifu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 252

Gifu Gifu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 432

Ginowan Okinawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 321

Habikino Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 29

Hachinohe Aomori, , Japan

Site Status

Boehringer Ingelheim Investigational Site 30

Hachinohe Aomori, , Japan

Site Status

Boehringer Ingelheim Investigational Site 176

Hachioji Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 209

Hadano Kanagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 3

Hakodate Hokkaido, , Japan

Site Status

Boehringer Ingelheim Investigational Site 349

Hamada Shimane, , Japan

Site Status

Boehringer Ingelheim Investigational Site 261

Hamamatsu Shizuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 367

Hatsukaichi Hiroshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 107

Hidaka Saitama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 76

Higashiibaraki Ibaraki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 53

Higashiokitama Yamagata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 54

Higashiokitama Yamagata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 318

Higashiosaka Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 339

Himeji Hyogo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 316

Hirakata Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 317

Hirakata Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 208

Hiratsuka Kanagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 31

Hirosaki Aomori, , Japan

Site Status

Boehringer Ingelheim Investigational Site 32

Hirosaki Aomori, , Japan

Site Status

Boehringer Ingelheim Investigational Site 359

Hiroshima Hiroshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 360

Hiroshima Hiroshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 361

Hiroshima Hiroshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 362

Hiroshima Hiroshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 363

Hiroshima Hiroshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 364

Hiroshima Hiroshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 79

Hitachi Ibaraki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 77

Hitachinaka Ibaraki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 78

Hitachinaka Ibaraki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 312

Ibaraki Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 131

Ichihara Chiba, , Japan

Site Status

Boehringer Ingelheim Investigational Site 120

Ichikawa Chiba, , Japan

Site Status

Boehringer Ingelheim Investigational Site 246

Iida Nagano, , Japan

Site Status

Boehringer Ingelheim Investigational Site 247

Iida Nagano, , Japan

Site Status

Boehringer Ingelheim Investigational Site 309

Ikeda Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 248

Ina Nagano, , Japan

Site Status

Boehringer Ingelheim Investigational Site 118

Inzai Chiba, , Japan

Site Status

Boehringer Ingelheim Investigational Site 105

Iruma Saitama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 428

Isa Kagoshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 407

Isahaya Nagasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 281

Ise Mie, , Japan

Site Status

Boehringer Ingelheim Investigational Site 95

Isesaki Gumma, , Japan

Site Status

Boehringer Ingelheim Investigational Site 168

Itabashi Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 65

Iwaki Fukushima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 368

Iwakuni Yamaguchi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 17

Iwamizawa Hokkaido, , Japan

Site Status

Boehringer Ingelheim Investigational Site 324

Izumi Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 348

Izumo Shimane, , Japan

Site Status

Boehringer Ingelheim Investigational Site 255

Izunokuni Shizuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 213

Joetsu Niigata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 214

Joetsu Niigata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 289

Joyo Kyoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 422

Kagoshima Kagoshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 423

Kagoshima Kagoshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 424

Kagoshima Kagoshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 425

Kagoshima Kagoshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 426

Kagoshima Kagoshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 262

Kakegawa Shizuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 340

Kakogawa Hyogo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 201

Kamakura Kanagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 202

Kamakura Kanagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 130

Kamogawa Chiba, , Japan

Site Status

Boehringer Ingelheim Investigational Site 223

Kanazawa Ishikawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 224

Kanazawa Ishikawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 225

Kanazawa Ishikawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 226

Kanazawa Ishikawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 227

Kanazawa Ishikawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 74

Kasama Ibaraki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 343

Kashihara Nara, , Japan

Site Status

Boehringer Ingelheim Investigational Site 123

Kashiwa Chiba, , Japan

Site Status

Boehringer Ingelheim Investigational Site 124

Kashiwa Chiba, , Japan

Site Status

Boehringer Ingelheim Investigational Site 125

Kashiwa Chiba, , Japan

Site Status

Boehringer Ingelheim Investigational Site 104

Kasukabe Saitama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 106

Kawagoe Saitama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 100

Kawaguchi Saitama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 99

Kawaguchi Saitama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 182

Kawasaki Kanagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 183

Kawasaki Kanagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 184

Kawasaki Kanagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 185

Kawasaki Kanagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 186

Kawasaki Kanagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 42

Kesennuma Miyagi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 129

Kisarazu Chiba, , Japan

Site Status

Boehringer Ingelheim Investigational Site 325

Kishiwada Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 326

Kishiwada Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 377

Kita Kagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 110

Kitaadachi Saitama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 387

Kitakyushu Fukuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 388

Kitakyushu Fukuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 389

Kitakyushu Fukuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 390

Kitakyushu Fukuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 391

Kitakyushu Fukuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 392

Kitakyushu Fukuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 25

Kitami Hokkaido, , Japan

Site Status

Boehringer Ingelheim Investigational Site 26

Kitami Hokkaido, , Japan

Site Status

Boehringer Ingelheim Investigational Site 180

Kiyose Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 181

Kiyose Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 327

Kobe Hyogo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 328

Kobe Hyogo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 329

Kobe Hyogo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 330

Kobe Hyogo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 331

Kobe Hyogo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 383

Kochi Kochi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 384

Kochi Kochi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 385

Kochi Kochi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 386

Kochi Kochi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 174

Kodaira Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 233

Kofu Yamanashi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 397

Koga Fukuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 398

Koga Fukuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 179

Komae Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 228

Komatsu Ishikawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 61

Koriyama Fukushima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 62

Koriyama Fukushima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 63

Koriyama Fukushima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 103

Koshigaya Saitama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 149

Koto Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 150

Koto Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 108

Kumagaya Saitama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 109

Kumagaya Saitama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 411

Kumamoto Kumamoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 413

Kumamoto Kumamoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 414

Kumamoto Kumamoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 415

Kumamoto Kumamoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 352

Kurashiki Okayama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 355

Kurashiki Okayama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 365

Kure Hiroshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 366

Kure Hiroshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 24

Kushiro, , Japan

Site Status

Boehringer Ingelheim Investigational Site 278

Kuwana Mie, , Japan

Site Status

Boehringer Ingelheim Investigational Site 285

Kyoto Kyoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 286

Kyoto Kyoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 287

Kyoto Kyoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 288

Kyoto Kyoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 291

Kyoto Kyoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 292

Kyoto Kyoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 293

Kyoto Kyoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 177

Machida Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 91

Maebashi Gumma, , Japan

Site Status

Boehringer Ingelheim Investigational Site 92

Maebashi Gumma, , Japan

Site Status

Boehringer Ingelheim Investigational Site 93

Maebashi Gumma, , Japan

Site Status

Boehringer Ingelheim Investigational Site 94

Maebashi Gumma, , Japan

Site Status

Boehringer Ingelheim Investigational Site 119

Matsudo Chiba, , Japan

Site Status

Boehringer Ingelheim Investigational Site 346

Matsue Shimane, , Japan

Site Status

Boehringer Ingelheim Investigational Site 347

Matsue Shimane, , Japan

Site Status

Boehringer Ingelheim Investigational Site 241

Matsumoto Nagano, , Japan

Site Status

Boehringer Ingelheim Investigational Site 242

Matsumoto Nagano, , Japan

Site Status

Boehringer Ingelheim Investigational Site 243

Matsumoto Nagano, , Japan

Site Status

Boehringer Ingelheim Investigational Site 244

Matsumoto Nagano, , Japan

Site Status

Boehringer Ingelheim Investigational Site 249

Matsumoto Nagano, , Japan

Site Status

Boehringer Ingelheim Investigational Site 250

Matsumoto Nagano, , Japan

Site Status

Boehringer Ingelheim Investigational Site 280

Matsusaka Mie, , Japan

Site Status

Boehringer Ingelheim Investigational Site 378

Matsuyama Ehime, , Japan

Site Status

Boehringer Ingelheim Investigational Site 379

Matsuyama Ehime, , Japan

Site Status

Boehringer Ingelheim Investigational Site 381

Matsuyama Ehime, , Japan

Site Status

Boehringer Ingelheim Investigational Site 158

Meguro Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 159

Meguro Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 416

Minamata Kumamoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 137

Minato Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 138

Minato Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 139

Minato Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 140

Minato Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 171

Mitaka Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 172

Mitaka Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 75

Mito Ibaraki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 419

Miyazaki Miyazaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 420

Miyazaki Miyazaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 421

Miyazaki Miyazaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 315

Moriguchi Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 33

Morioka Iwate, , Japan

Site Status

Boehringer Ingelheim Investigational Site 34

Morioka Iwate, , Japan

Site Status

Boehringer Ingelheim Investigational Site 282

Moriyama Shiga, , Japan

Site Status

Boehringer Ingelheim Investigational Site 283

Moriyama Shiga, , Japan

Site Status

Boehringer Ingelheim Investigational Site 5

Muroran Hokkaido, , Japan

Site Status

Boehringer Ingelheim Investigational Site 284

Nagahama Shiga, , Japan

Site Status

Boehringer Ingelheim Investigational Site 274

Nagakute Aichi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 236

Nagano Nagano, , Japan

Site Status

Boehringer Ingelheim Investigational Site 237

Nagano Nagano, , Japan

Site Status

Boehringer Ingelheim Investigational Site 238

Nagano Nagano, , Japan

Site Status

Boehringer Ingelheim Investigational Site 210

Nagaoka Niigata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 211

Nagaoka Niigata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 212

Nagaoka Niigata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 405

Nagasaki Nagasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 406

Nagasaki Nagasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 267

Nagoya Aichi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 268

Nagoya Aichi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 269

Nagoya Aichi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 270

Nagoya Aichi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 271

Nagoya Aichi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 272

Nagoya Aichi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 80

Naka Ibaraki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 167

Nakano Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 341

Nara Nara, , Japan

Site Status

Boehringer Ingelheim Investigational Site 122

Narashino Chiba, , Japan

Site Status

Boehringer Ingelheim Investigational Site 39

Natori Miyagi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 169

Nerima Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 170

Nerima Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 215

Niigata Niigata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 216

Niigata Niigata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 217

Niigata Niigata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 218

Niigata Niigata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 382

Niihama Ehime, , Japan

Site Status

Boehringer Ingelheim Investigational Site 334

Nishinomiya Hyogo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 335

Nishinomiya Hyogo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 336

Nishinomiya Hyogo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 22

Obihiro Hokkaido, , Japan

Site Status

Boehringer Ingelheim Investigational Site 23

Obihiro Hokkaido, , Japan

Site Status

Boehringer Ingelheim Investigational Site 253

Ogaki Gifu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 417

Oita Oita, , Japan

Site Status

Boehringer Ingelheim Investigational Site 418

Oita Oita, , Japan

Site Status

Boehringer Ingelheim Investigational Site 350

Okayama Okayama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 351

Okayama Okayama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 353

Okayama Okayama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 264

Okazaki Aichi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 265

Okazaki Aichi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 178

Ome Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 358

Onomichi Hiroshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 295

Osaka Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 296

Osaka Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 297

Osaka Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 298

Osaka Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 299

Osaka Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 300

Osaka Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 301

Osaka Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 302

Osaka Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 303

Osaka Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 304

Osaka Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 305

Osaka Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 306

Osaka Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 307

Osaka Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 43

Osaki Miyagi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 35

Oshu Iwate, , Japan

Site Status

Boehringer Ingelheim Investigational Site 96

Ota Gumma, , Japan

Site Status

Boehringer Ingelheim Investigational Site 153

Ota Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 154

Ota Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 155

Ota Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 156

Ota Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 4

Otaru Hokkaido, , Japan

Site Status

Boehringer Ingelheim Investigational Site 85

Otawara Tochigi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 70

Ryugasaki Ibaraki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 403

Saga Saga, , Japan

Site Status

Boehringer Ingelheim Investigational Site 204

Sagamihara Kanagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 205

Sagamihara Kanagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 206

Sagamihara Kanagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 207

Sagamihara Kanagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 322

Sakai Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 323

Sakai Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 56

Sakata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 57

Sakata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 239

Saku Nagano, , Japan

Site Status

Boehringer Ingelheim Investigational Site 126

Sakura Chiba, , Japan

Site Status

Boehringer Ingelheim Investigational Site 338

Sanda Hyogo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 10

Sapporo Hokkaido, , Japan

Site Status

Boehringer Ingelheim Investigational Site 11

Sapporo Hokkaido, , Japan

Site Status

Boehringer Ingelheim Investigational Site 12

Sapporo Hokkaido, , Japan

Site Status

Boehringer Ingelheim Investigational Site 13

Sapporo Hokkaido, , Japan

Site Status

Boehringer Ingelheim Investigational Site 14

Sapporo Hokkaido, , Japan

Site Status

Boehringer Ingelheim Investigational Site 15

Sapporo Hokkaido, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Sapporo Hokkaido, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Sapporo Hokkaido, , Japan

Site Status

Boehringer Ingelheim Investigational Site 7

Sapporo Hokkaido, , Japan

Site Status

Boehringer Ingelheim Investigational Site 8

Sapporo Hokkaido, , Japan

Site Status

Boehringer Ingelheim Investigational Site 9

Sapporo Hokkaido, , Japan

Site Status

Boehringer Ingelheim Investigational Site 409

Sasebo Nagasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 410

Sasebo Nagasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 73

Sashima Ibaraki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 427

Satsumasendai Kagoshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 36

Sendai Miyagi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 37

Sendai Miyagi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 38

Sendai Miyagi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 40

Sendai Miyagi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 275

Seto Aichi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 219

Shibata Niigata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 98

Shibukawa Gumma, , Japan

Site Status

Boehringer Ingelheim Investigational Site 157

Shibuya Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 408

Shimabara Nagasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 430

Shimajiri Okinawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 369

Shimonoseki Yamaguchi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 371

Shimonoseki Yamaguchi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 372

Shimonoseki Yamaguchi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 83

Shimotsuga Tochigi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 84

Shimotsuga Tochigi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 87

Shimotsuke Tochigi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 88

Shimotsuke Tochigi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 151

Shinagawa Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 152

Shinagawa Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 160

Shinjuku Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 161

Shinjuku Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 162

Shinjuku Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 163

Shinjuku Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 164

Shinjuku Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 165

Shinjuku Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 166

Shinjuku Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 41

Shiogama Miyagi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 258

Shizuoka Shizuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 259

Shizuoka Shizuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 102

Soka Saitama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 310

Suita Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 311

Suita Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 146

Sumida Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 332

Sumoto Hyogo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 256

Sunto Shizuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 245

Suwa Nagano, , Japan

Site Status

Boehringer Ingelheim Investigational Site 175

Tachikawa Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 141

Taito Tokyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 376

Takamatsu Kagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 222

Takaoka Toyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 337

Takarazuka Hyogo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 89

Takasaki Gumma, , Japan

Site Status

Boehringer Ingelheim Investigational Site 90

Takasaki Gumma, , Japan

Site Status

Boehringer Ingelheim Investigational Site 313

Takatsuki Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 314

Takatsuki Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 254

Takayama Gifu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 342

Tenri Nara, , Japan

Site Status

Boehringer Ingelheim Investigational Site 86

Tochigi Tochigi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 101

Toda Saitama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 373

Tokushima Tokushima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 374

Tokushima Tokushima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 375

Tokushima Tokushima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 6

Tomakomai Hokkaido, , Japan

Site Status

Boehringer Ingelheim Investigational Site 380

Toon Ehime, , Japan

Site Status

Boehringer Ingelheim Investigational Site 71

Toride Ibaraki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 220

Toyama Toyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 221

Toyama Toyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 263

Toyohashi Aichi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 308

Toyonaka Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 273

Toyota Aichi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 279

Tsu Mie, , Japan

Site Status

Boehringer Ingelheim Investigational Site 66

Tsuchiura Ibaraki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 67

Tsuchiura Ibaraki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 68

Tsuchiura Ibaraki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 69

Tsukuba Ibaraki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 72

Tsukuba Ibaraki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 55

Tsuruoka Yamagata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 354

Tsuyama Okayama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 370

Ube Yamaguchi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 240

Ueda Nagano, , Japan

Site Status

Boehringer Ingelheim Investigational Site 290

Uji Kyoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 431

Urasoe Okinawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 404

Ureshino Saga, , Japan

Site Status

Boehringer Ingelheim Investigational Site 81

Utsunomiya Tochigi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 82

Utsunomiya Tochigi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 344

Wakayama Wakayama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 412

Yamaga Kumamoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 49

Yamagata Yamagata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 50

Yamagata Yamagata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 51

Yamagata Yamagata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 52

Yamagata Yamagata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 197

Yamato Kanagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 401

Yanagawa Fukuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 319

Yao Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 320

Yao Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 276

Yokkaichi Mie, , Japan

Site Status

Boehringer Ingelheim Investigational Site 277

Yokkaichi Mie, , Japan

Site Status

Boehringer Ingelheim Investigational Site 187

Yokohama Kanagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 188

Yokohama Kanagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 189

Yokohama Kanagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 190

Yokohama Kanagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 191

Yokohama Kanagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 194

Yokohama Kanagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 195

Yokohama Kanagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 196

Yokohama Kanagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 199

Yokohama Kanagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 200

Yokohama Kanagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 192

Yokosuka Kanagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 193

Yokosuka Kanagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 345

Yonago Tottori, , Japan

Site Status

Boehringer Ingelheim Investigational Site 229

Yoshida Fukui, , Japan

Site Status

Boehringer Ingelheim Investigational Site 230

Yoshida Fukui, , Japan

Site Status

Boehringer Ingelheim Investigational Site 400

Yukuhashi Fukuoka, , Japan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Japan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1200.181

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

An Open Label Trial of Afatinib (Giotrif) in Treatment-naive (1st Line) or Chemotherapy Pre-treated Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s)
NCT01853826 COMPLETED PHASE3
Afatinib (BIBW 2992) in Advanced Non-Small Cell Lung Cancer Patients With EGFR Mutation
NCT01953913 COMPLETED PHASE3
A Study in the United States Using Electronic Medical Records (EMR) to Assess Effectiveness of Afatinib (Gilotrif) Following Pembrolizumab and Chemotherapy in the Treatment of Metastatic Squamous Cell Carcinoma of the Lung
NCT04552535 COMPLETED
Afatinib in NSCLC With HER2 Mutation
NCT02597946 COMPLETED PHASE2
Real World Data on Gi(l)Otrif® Dose Adjustment
NCT02751879 COMPLETED
Afatinib in EGFR+NSCLC (Recurrent or Stage IV) - Patients With Poor Performance Status (ECOG 2 or 3)
NCT02695290 TERMINATED PHASE4
Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older
NCT02514174 COMPLETED PHASE4
Apatinib in Advanced Non-squamous，NSCLC
NCT03376191 UNKNOWN
Real-World Effectiveness of Afatinib (Gilotrif) Following Immunotherapy in the Treatment of Metastatic, Squamous Cell Carcinoma of the Lung: A Multi-Site Retrospective Chart Review Study in the U.S.
NCT04750824 COMPLETED
The Efficacy and Safety of Apatinib Monotherapy in Maintenance Treatment of Extensive-stage Small-cell Lung Cancer
NCT03129698 UNKNOWN PHASE2
Neoadjuvant Afatinib Therapy for Potentially Resectable Stage III EGFR Mutation-Positive Lung Adenocarcinoma
NCT04201756 COMPLETED PHASE2
Efficacy and Safety Study of Afatinib to Treat Lung Cancer Patients
NCT01415011 COMPLETED PHASE2
Abivertinib Maleate Versus Geifitinib in Patients With Advanced Non-small Cell Lung Cancer With Sensitive EGFR Mutation
NCT03856697 UNKNOWN PHASE3
Maintenance Therapy of Apatinib After Chemoradiotherapy in Metastatic Nasopharyngeal Carcinoma
NCT03180476 COMPLETED PHASE2
Adjuvant Afatinib in Stage I-III NSCLC With EGFR Mutation
NCT01746251 UNKNOWN PHASE2
Afatinib and Selumetinib in Advanced KRAS Mutant and PIK3CA Wildtype Non-small Cell Lung Cancer
NCT02450656 UNKNOWN PHASE1/PHASE2
The Efficacy and Drug Resistance Molecular Biology of Apatinib Combined With EGFR-TK1 Treated for Advanced Slow-progressed Non-Small Cell Lung Cancer (NSCLC)
NCT03811054 UNKNOWN PHASE2
Expanded Access Study of Afatinib in Treatment-naive or Chemotherapy Pre-treated Patients With Non-small Cell Lung Cancer (NSCLC)
NCT01931306 APPROVED_FOR_MARKETING
Gefitinib With Chemotherapy or Anti-angiogenesis in NSCLC Patients With Bim Deletion or Low EGFR Mutation Abundance
NCT03267654 UNKNOWN PHASE2
Afatinib Osimertinib Sequencing NIS
NCT03370770 COMPLETED
To Evaluate the Efficacy of Afatinib in Advanced Lung Squamous Cell Carcinoma With EGFR Sensitive Mutation
NCT04132102 UNKNOWN PHASE4
Afatinib Plus Nimotuzumb for NSCLC
NCT01861223 UNKNOWN PHASE1/PHASE2
Maintaining ERBB Blockade in EGFR-mutated Lung Cancer
NCT02488694 TERMINATED PHASE2
Apatinib Plus Anti-PD1 Therapy for Advanced Osteosarcoma
NCT03359018 COMPLETED PHASE2
Selumetinib in Combination With Gefitinib in NSCLC Patients
NCT02025114 COMPLETED PHASE1/PHASE2